Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019

SELL
$27.23 - $45.56 $251,060 - $420,063
-9,220 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$37.57 - $50.34 $49,103 - $65,794
1,307 Added 16.52%
9,220 $424,000
Q2 2018

Aug 14, 2018

SELL
$27.75 - $40.17 $260,406 - $376,955
-9,384 Reduced 54.25%
7,913 $296,000
Q1 2018

May 15, 2018

BUY
$28.83 - $41.01 $498,672 - $709,349
17,297 New
17,297 $511,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.77B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.